Chemical-based epigenetic reprogramming to advance pluripotency and totipotency

被引:0
作者
Wen, Shanshan [1 ]
Zheng, Ran [2 ]
Cai, Cheguo [2 ]
Jiang, Wei [1 ,3 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Frontier Sci Ctr Immunol & Metab, Med Res Inst,Dept Biol Repositories, Wuhan, Peoples R China
[2] Shenzhen Beike Biotechnol Co Ltd, Shenzhen, Peoples R China
[3] Hubei Prov Key Lab Dev Originated Dis, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
STEM-CELLS; SOMATIC-CELLS; GROUND-STATE; INDUCTION; DERIVATION; DRUG; ESTABLISHMENT; FIBROBLASTS; GENERATION; CIRCUITRY;
D O I
10.1038/s41589-025-01874-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Reprogramming technology, breaking the inherent limitations of cellular identity and turning somatic cells into pluripotent cells with more developmental potential, holds great promise for cell therapy and regenerative medicine. Compared with traditional methods based on overexpressing transcription factors, chemical reprogramming with small molecules exhibits substantial advantages in safety and convenience, thus being the leading edge. Over the past decade, a notable focus has been reshaping cellular pluripotency and totipotency using pure small-molecule systems. Here, we provide a concise Review comparing the chemical approaches that have emerged to date and discussing the epigenetic regulatory mechanisms involved in chemical reprogramming. This Review highlights the remarkable potential of small-molecule potions to reformulate cell fate through epigenetic reprogramming and newly discovered actions. We aim to offer insights into chemically controlled cell manipulation and key challenges and future application prospects of chemical reprogramming.
引用
收藏
页码:635 / 647
页数:13
相关论文
共 34 条
  • [21] Reprogramming fibroblasts to pluripotency using arginine-terminated polyamidoamine nanoparticles based non-viral gene delivery system
    Zhu, Kai
    Li, Jun
    Lai, Hao
    Yang, Cheng
    Guo, Changfa
    Wang, Chunsheng
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2014, 9 : 5837 - 5847
  • [22] Going up the hill: chromatin-based barriers to epigenetic reprogramming
    Arabaci, Dilsad H.
    Terzioglu, Gizem
    Bayirbasi, Busra
    Onder, Tamer T.
    FEBS JOURNAL, 2021, 288 (16) : 4798 - 4811
  • [23] A XEN-like State Bridges Somatic Cells to Pluripotency during Chemical Reprogramming
    Zhao, Yang
    Zhao, Ting
    Guan, Jingyang
    Zhang, Xu
    Fu, Yao
    Ye, Junqing
    Zhu, Jialiang
    Meng, Gaofan
    Ge, Jian
    Yang, Susu
    Cheng, Lin
    Du, Yaqin
    Zhao, Chaoran
    Wang, Ting
    Su, Linlin
    Yang, Weifeng
    Deng, Hongkui
    CELL, 2015, 163 (07) : 1678 - 1691
  • [24] Advance in the Role of Epigenetic Reprogramming in Somatic Cell Nuclear Transfer-Mediated Embryonic Development
    Zhang, Xiaolei
    Gao, Shaorong
    Liu, Xiaoyu
    STEM CELLS INTERNATIONAL, 2021, 2021
  • [25] Transcriptome-based chemical screens identify CDK8 as a common barrier in multiple cell reprogramming systems
    Li, Jun
    Bai, Yunfei
    Liu, Yang
    Song, Zhongya
    Yang, Yong
    Zhao, Yang
    CELL REPORTS, 2023, 42 (06):
  • [26] Chemical-based Hydrogen Storage Systems: Recent Developments, Challenges, and Prospectives
    Ali, Shahid
    Abbas, Noreen
    Khan, Safyan Akram
    Malik, Imran
    Mansha, Muhammad
    CHEMISTRY-AN ASIAN JOURNAL, 2024, 19 (16)
  • [27] Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming
    Zhang, X.
    Cruz, F. D.
    Terry, M.
    Remotti, F.
    Matushansky, I.
    ONCOGENE, 2013, 32 (18) : 2249 - 2260
  • [28] Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming
    X Zhang
    F D Cruz
    M Terry
    F Remotti
    I Matushansky
    Oncogene, 2013, 32 : 2249 - 2260
  • [29] Chemical-based resistance of Brassica oleracea and Rorippa dubia in response to Spodoptera litura attack
    Anh-Tuan Pham
    Hwang, Shaw-Yhi
    JOURNAL OF APPLIED ENTOMOLOGY, 2020, 144 (03) : 201 - 211
  • [30] A CRISPR/Cas9-based kinome screen identifies ErbB signaling as a new regulator of human naïve pluripotency and totipotency
    Li, Jiayu
    Lin, Xiwen
    Xie, Liangfu
    Zhao, Jingru
    Han, Chunsheng
    Deng, Hongkui
    Xu, Jun
    LIFE MEDICINE, 2023, 2 (04):